MTOR and hepatocellular carcinoma: mTOR inhibitors target the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR signaling pathway, which has at least two mTOR complexes, m-TOR complex 1 and m-TOR complex 2, that can lead to HCC proliferation and spreading [77,78].